Treatment of canine CD3+/CD21+/CD45- T-zone lymphoma with chlorambucil and prednisolone in two dogs: case reports
- Author:
Hee-Tae PARK
1
;
Jeong-Min LEE
;
Hyeon-A BAE
;
Do-Hyeon YU
;
Dong-In JUNG
;
Kun-Ho SONG
;
Joong-Hyun SONG
Author Information
- Publication Type:Case Report
- From:Korean Journal of Veterinary Research 2023;63(4):e38-
- CountryRepublic of Korea
- Language:English
- Abstract: Canine T-zone lymphoma (TZL) is an indolent form of T-cell lymphoma. Conservative management is usually recommended; however, chemotherapy may be considered for symptomatic or progressive cases. Herein, we describe two dogs with generalized peripheral lymphadenopathy and peripheral blood lymphocytosis at presentation. One dog presented with gross lesions on the tongue. Flow cytometric immunophenotyping and cytological examinations demonstrated findings consistent with those of TZL. Chemotherapy with chlorambucil and prednisolone was administered, which resulted in improvement of the condition without any adverse events. Chemotherapy with chlorambucil may be considered as an appropriate choice for treating canine TZL.
